![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
Advertisement
![Picture [iito] Back into Ad 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-back-into-ad.jpg)
Persons > All
Find below all kinds of persons.Total search results: 7310 | Ordered by Person (ascending)
1 2 3 ... 15 16 17 ... 72 73 74 
  Person |
 Position |
Organisation (Group) |
Country |
|---|---|---|---|
| Ehret, Ralf (Bionas 2001–201007– Managing Director + Founder) | Managing Director | Bionas GmbH | Germany |
| Ehrhardt, Thomas (BASF 201905– Managing Director of BASF Metabolome Solutions GmbH) | Managing Director | BASF (Group) | Germany |
| Ehring, Björn (Lacerta Technologies GmbH 201404 CFO + Business Angel Investor) | Chief Financial Officer (CFO) | OrthoSera (Group) | Austria |
| Ehrlich, Andre (BromMarin GmbH 201704 Managing Director) | Managing Director | BromMarin GmbH | Germany |
| Eichelberg, Rolf (SIM Scientific Instruments Manufacturer 201003 Managing Director) | Managing Director | SIM Scientific Instruments Manufacturer GmbH | Germany |
| Eichenberg, Klaus (BioRegio STERN 200601 Managing Director) | Managing Director | BioRegio STERN Management GmbH | Germany |
| Eichhorn, Anna C. (Humatrix AG 200703 founder + Vorstand) | Company Founder | R-Biopharm (Group) | Germany |
| Eickhoff, Bodo (Roche 201008 Head Sales + Marketing Roche Applied Sciences Germany) | Sales Manager / Marketing Manager | Roche (Group) | United States (USA) |
| Eickhoff, Holger (Scienion 200012–201008– CEO + co-founder) | Chief Executive Officer (CEO) | Scienion (Group) | Germany |
| Eiden, Frank (Technical University Dortmund 200808) | n. a. | Technical University Darmstadt (TU Darmstadt) | Germany |
| Eidens, Dietmar (Merck DE 201607– Chief Human Resources Manager joind Merck 2009) | Human Resources Manager | Merck (DE) (Group) | Germany |
| Eidens, Moritz (PharmGenomics GmbH 201601 Managing Director) | Managing Director | PharmGenomics GmbH | Germany |
| Eigen, Manfred | Nobel prize | Max Planck Society for the Advancement of Science | Germany |
| Eigner, Ulrich (Labor Limbach 201405) | n. a. | Labor Limbach (Group) | Germany |
| Eijsackers, Marco (Danaher 201504 VP Sales + Customer Support + General Manager EMEAI at AB Sciex) | Sales Manager / Marketing Manager | Danaher (Group) | Germany |
| Eiler, John (Caltech 201512 Professor of Geology + Geochemistry) | Professor | Caltech (California Institute of Technology) | United States (USA) |
| Eils, Roland (Helmholtz 201006 Professor DKFZ Heidelberg) | Professor | Helmholtz-Gemeinschaft (HGF) (Group) | Germany |
| Einhäupl, Karl Max (Charité Berlin) | n. a. | Humboldt University Berlin | Germany |
| Eise, Bernd (BGI Biotechpark Gatersleben 201206 Managing Director) | Managing Director | BGI Biotechpark Gatersleben Infrastrukturgesellschaft mbH | Germany |
| Eisele, Bernd (VPM Vakzine Projekt Management GmbH 201201 CEO) | Managing Director | Deutsche Stiftung Impfstoffforschung | Germany |
| Eisenberg, Marcia (LabCorp 201904 CSO of LabCorp Diagnostics) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | LabCorp (Group) | United States (USA) |
| Eisenführ, Günther | n. a. | Eisenführ Speiser Patentanwälte Rechtsanwälte PartGmbB | Germany |
| Eisenhaber, Frank | n. a. | Boehringer Ingelheim (Group) | Austria |
| Eistetter, Harald (Rhecadis 201201– Managing Director + Co-Founder before Biognosys CBO + EvalueScience + Indivumed) | Managing Director | Rhecadis GmbH | Germany |
| Eklund, Dario (Santhera 201912– CEO before Vifor Pharma + Organogenesis + Novartis + Sanofi) | Chief Executive Officer (CEO) | Santhera (Group) | Switzerland |
| El Khoury, Mohammad (Qiagen 201610 President + Head of Commercial Operations EMEA) | Chief Commercial Officer (CCO) | Qiagen (Group) | Germany |
| Elbers, Knut (Boehringer Ingelheim 201204 Investment Manager + Director Boehringer Ingelheim Venture Fund) | Investment Manager | Boehringer Ingelheim Venture Fund (BIVF) | Germany |
| Elbl, Gabriele (MorphoSys 201312– Head of Regulatory Affairs before Wilex + EMA + Sanofi Winthrop) | Regulatory Affairs Manager | MorphoSys (Group) | Germany |
| Elbraechter, Hanno (DKSH 201804 Head Business Unit Technology) | President/Director/Head Business Group/Unit/Division | DKSH (Group) | Switzerland |
| Eletr, Sam (Third Wave Technologies 200504 Director) | Board member | Hologic (Group) | United States (USA) |
| Elff, Manfred (Niedersächsisches Zentrum für Biomedizintechnik und Implantatforschung 201009 Managing Director) | Managing Director | Niedersächsisches Zentrum für Biomedizintechnik und Implantatforschung (NZ-BMT) | |
| Elger, Daniel (Genkyotec 201406– CFO + Chief Development Officer before e-Therapeutics plc + Antisoma) | Chief Financial Officer (CFO) | Genkyotex (Group) | Switzerland |
| Ellam, David (Juvenescence 201904– CFO before Silence Therapeutics + BioMarin + Plethora Solutions + Ark Therapeutics) | Chief Financial Officer (CFO) | Juvenescence (Group) | United Kingdom (GB) |
| Elliott, Mary-Jane (Consilium SC 201307– Managing Partner + Co-founder before M:Communications) | Public Relations Manager / Investor Relations Manager | Consilium Strategic Communications Ltd. (CSC) | United Kingdom (GB) |
| Ellmann, Felix (M.M. Warburg 200909 Managing Director + Analyst SES Research GmbH) | Analyst (Financial / Industry) | M.M. Warburg (Group) | Germany |
| Ellrich, Jens (Sapiens CMO) | Consultant (economic/technology) | Medtronic (Group) | Netherlands |
| Elssner, Thomas (Bruker Corp 201708 Bio-Dection Manager at Bruker Detection division) | n. a. | Bruker Corporation (Group) | Germany |
| Emler, Stefan (SmartGene 201108 CEO) | Chief Executive Officer (CEO) | SmartGene (Group) | Switzerland |
| Emmenegger, Andreas (Molecular Partners 201603 CFO) | Chief Financial Officer (CFO) | Molecular Partners AG (SIX: MOLN) | Switzerland |
| Emmerich, Niels (AbbVie 201504– Global Head Search + Evaluation Oncology joined 201110 before Biopheresis + Immatics) | Business Development Manager / Strategy Manager | AbbVie (Group) | United States (USA) |
| Emmerich, Ralf (Aurelia Private Equity 200201–) | n. a. | Aurelia (Group) | Germany |
| Emmerich, Wolf-Dieter (Netzsch Instruments) | Consultant (economic/technology) | Netzsch (Group) | Germany |
| Emmerth, Stephan (BaseLaunch 202009 Director BusDev + Operations at BaseLaunch) | Business Development Manager / Strategy Manager | Basel (govt city) | Switzerland |
| Emmick, Jeff (Lilly 201706 VP Product Development at Lilly Diabetes) | Research & Development Manager | Eli Lilly (Group) | United States (USA) |
| Enderle, Thilo (Max Planck 202001 Managing Director at Hit Discovery Constance) | Managing Director | Max Planck Society for the Advancement of Science | Germany |
| Endress, Klaus (Endress+Hauser 201309 CEO) | Chief Executive Officer (CEO) | Endress+Hauser (Group) | Switzerland |
| Engel, Jürgen (Æterna Zentaris 200504) | Chief Operating Officer (COO) | Æterna Zentaris (Group) | Canada |
| Engel, Klaus (Evonik 201112 Chairman of Executive Board) | Chief Executive Officer (CEO) | Evonik (Group) | Germany |
| Engel, Sven (Amantec GmbH 201108 Managing Director) | Managing Director | Sacura GmbH | Germany |
| Engeland, Birgit (AltonaBiotec 200810) | n. a. | AltonaBiotec AG | Germany |
| Engelen, Julie (SGS 201802 Investor Relations Manager) | Public Relations Manager / Investor Relations Manager | SGS (Group) | Switzerland |
| Engelhard, Markus (Boehmert & Boehmert 200501–200809–) | Patent Attorney | Boehmert & Boehmert (Patentanwälte) (Group) | Germany |
| Engeser, Marianne (Uni Bonn 200910 Head Div of Mass Spectrometry) | Head Mass Spectrometry / NMR Laboratory (university / research institute) | University of Bonn (Rheinsche Friedrich-Wilhelms-Universität Bonn) | Germany |
| Enghild, Jan J. (Aarhus Univ 201106 Professor Laboratory for Proteome Analysis and Protein Characterisation) | Professor | Aarhus University | Denmark |
| Enghofer, Erich (4SC 201406– EVP Oncology + Haematology before Bayer Healthcare) | President/Director/Head Business Group/Unit/Division | 4SC (Group) | Germany |
| England, Claire (Scott Partnership 201408 at Phoenix MarCom) | Public Relations Manager / Investor Relations Manager | Scott Partnership (Scott PR) (Group) | United Kingdom (GB) |
| Englbrecht, Claudia (BIO Deutschland 2013 Public Relations Manager) | public/private partnership | BIO Deutschland e. V. | Germany |
| Engleman, Katie (1AB Media 201903 before Pure Communications) | Public Relations Manager / Investor Relations Manager | 1AB Media (US) | United States (USA) |
| Englerth, Chris (Phlexglobal 202001 Head Global Marketing) | Sales Manager / Marketing Manager | Phlexglobal (Group) | United Kingdom (GB) |
| Engsig, Michael (Vaccibody 202010 CEO) | Chief Executive Officer (CEO) | Vaccibody AS | Norway |
| Enns, Timothy L. (KineMed 201401– Chief Investor + Media Relations Officer before Astex/SuperGen) | Public Relations Manager / Investor Relations Manager | KineMed Inc. | United States (USA) |
| Enyedy, Mark J. (ImmunoGen 201705 CEO before Genzyme 200803 President Genzyme Oncology) | Chief Executive Officer (CEO) | ImmunoGen Inc. (Nasdaq: IMGN) | United States (USA) |
| Enzelberger, Markus (Versant Ventures 202003– EIR in Basel before MorphoSys 2002–202002) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Versant Ventures | Switzerland |
| Epping-Jordan, Mark (Addex Pharma –200806 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Addex (Group) | Switzerland |
| Epstein, Barry (Proteomics International 201201 VP Marketing) | Sales Manager / Marketing Manager | Proteomics International Pty Ltd. | Australia |
| Epstein, David M. (Black Diamond Therapeutics 2017– CEO + Co-Founder) | Chief Executive Officer (CEO) | Black Diamond Therapeutics (Group) | United States (USA) |
| Epstein, David R. (Flagship Pioneering 201701– Executive Partner before Novartis –201605 Division Head Pharma LEFT 5/16) | Partner (venture partner) | Flagship Pioneering | United States (USA) |
| Epstein, Jake (Klein Hersh International 202002 Director of Business Development + Finance) | Business Development Manager / Strategy Manager | Klein Hersh International | United States (USA) |
| Erbe, Cornelius (vfa 202001 Managing Director) | Managing Director | VFA (Verband Forschender Arzneimittelhersteller e. V.) | Germany |
| Erdman, Chris (CRISPR Therapeutics 201711 Investor Relations) | Public Relations Manager / Investor Relations Manager | CRISPR Therapeutics (Group) | United States (USA) |
| Erdmann, Till (Myelo Therapeutics 201304– Managing Director) | Managing Director | Myelo Therapeutics GmbH | Germany |
| Erdmann, Winfried (Berthold Technologies 201106 European Sales Manager Bioanalytic) | Sales Manager / Marketing Manager | Berthold Technologies (Group) | Germany |
| Ergun, Elcin (Menarini 201909– CEO before Merck (DE) 201409 Head Global Commerical at Merck Serono) | Chief Executive Officer (CEO) | Menarini (Group) | Italy |
| Erhard, Marcel (AnagnosTec 1998–200912– CSO + co-founder) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | AnagnosTec Gesellschaft für Analytische Biochemie und Diagnostik mbH | Germany |
| Erhart, Benjamin (High-Tech Gründerfonds 201204 Investment Manager) | Investment Manager | High-Tech Gründerfonds (HTGF) (Group) | Germany |
| Eric Fotheringham (Waters 200601 Senior Product Manager) | Product Manager (personnel) | Waters (Group) | Germany |
| Erlen, Hubertus | n. a. | Bayer (Group) | Germany |
| Erlich, Henry (Roche 201103 Roche Molecular Systems Director of Dept of Human Genetics) | Researcher (industry) | Children’s Hospital Oakland | United States (USA) |
| Ermantraut, Eugen (Clondiag 200502 Managing Director) | Managing Director | Alere (Group) | Germany |
| Ernst, Bettina (Bernina BioInvest 202011 Director + InterAx Biotech 201901– Non-executive Board Member) | Board member, non-executive | InterAx Biotech AG | Switzerland |
| Ernst, Doreen (Analytik Jena 200809) | n. a. | Endress+Hauser (Group) | Germany |
| Erselius, Jörn R. (Max Planck Innovation Managing Director before Garching Innovation 200311) | Managing Director | Max Planck Society for the Advancement of Science | Germany |
| Erwin, M. Johnston (Eli Lilly 201603 VP Corporate Business Development) | Business Development Manager / Strategy Manager | Eli Lilly (Group) | United States (USA) |
| Eschenfelder, Christina (Rittershaus 201511 Lawyer) | Attorney / Lawyer | Rittershaus Rechtsanwälte Partnerschaftsgesellschaft mbH | Germany |
| Escher, Adrian (ESBATech 200205 CFO) | Chief Financial Officer (CFO) | Novartis (Group) | Switzerland |
| Escher, Dominik (Belleveue 201001 Managing Partner at BB Pureos Bioventures before ESBATech CEO + Founder) | Managing Partner | Bellevue (Group) | United Kingdom (GB) |
| Escher, Klaus | n. a. | BASF (Group) | Germany |
| Esper, Ralph (Eppendorf 201811– Head of Corporate Communications before Hagebau + Hamburger Sparkasse) | Public Relations Manager / Investor Relations Manager | Eppendorf (Group) | Germany |
| Esposito, Gloria (Artemis 200705– Project Manager) | n. a. | Taconic (Group) | Germany |
| Essenpreis, Matthias (Roche 201502 CTO of Roche Diagnostics) | Chief Technology/Technical Officer (CTO) | Roche (Group) | United States (USA) |
| Essig, Stuart M. (Wellington Partners 201303– Venture Partner before Integra Life Sciences CEO + Goldman Sachs) | Venture Partner | Wellington Partners (Group) | Germany |
| Essinger, Jacques R. (Symetis 201703 CEO) | Chief Executive Officer (CEO) | Boston Scientific (Group) | Switzerland |
| Esslinger, Christoph (Memo Therapeutics AG 202011 CSO + Co-Founder formerly CEO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Memo Therapeutics AG | Switzerland |
| Etches, Robert J. (Rob) (Crystal Bioscience 201401 CEO) | Chief Executive Officer (CEO) | Crystal Bioscience Inc. | United States (USA) |
| Ettenberg, Seth (Bayer 202003– CSO BlueRock Therapeutics before Unum Therapeutics + Novartis IBR + CuraGen) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Bayer (Group) | United States (USA) |
| Etzold, Thure (Lion Bioscience 200502–200604 CEO resigned) | Chief Executive Officer (CEO) | Expedeon (Group) | Germany |
| Eugster, Rudolf (Tecan 200212–20203 CFO RETIRED 3/20) | Chief Financial Officer (CFO) | Tecan (Group) | Switzerland |
| Eul, Wilfried (Evonik 201207 SVP + Head Catalysts Business Line) | President/Director/Head Business Group/Unit/Division | Evonik (Group) | Germany |
| Euller, Gordon (Apex Ventures 202010 Partner Digital Health) | Partner (venture partner) | Apex Ventures (Group) | Austria |
| Evans, David (Syngenta 200404) | n. a. | Syngenta (Group) | Switzerland |
1 2 3 ... 15 16 17 ... 72 73 74
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
